Search - tctmd.com

Displaying 1 - 20 of 22

Sort: Relevancy | Date

SURPASS-CVOT Published: Large Trial Confirms CVD Efficacy of Tirzepatide

News Daily News

SURPASS-CVOT Published: Large Trial Confirms CVD Efficacy of Tirzepatide

Michael O'Riordan

December 18, 2025

High Aerobic Fitness Linked to Less Chronic Disease in Later Life

News Daily News

High Aerobic Fitness Linked to Less Chronic Disease in Later Life

Michael O'Riordan

October 10, 2025

AI-Supported Coaching Shows Promise for Improving Glycemic Control

News Daily News

AI-Supported Coaching Shows Promise for Improving Glycemic Control

August 25, 2025

Weight-Loss Medications Should Be Part of Cardiology’s Arsenal: ACC

News Daily News

Weight-Loss Medications Should Be Part of Cardiology’s Arsenal: ACC

Michael O'Riordan

June 25, 2025

Majority of US Adults Have High Long-term Risk of CVD: NHANES

News Daily News

Majority of US Adults Have High Long-term Risk of CVD: NHANES

Michael O'Riordan

June 13, 2025

Variety of GLP-1 Drugs Help People Without Diabetes Lose Weight: Review

News Daily News

Variety of GLP-1 Drugs Help People Without Diabetes Lose Weight: Review

January 09, 2025

Top General Cardiology and Prevention News of 2024

News Daily News

Top General Cardiology and Prevention News of 2024

December 30, 2024

Burden of CVD Still High in UK Despite Prevention Efforts Over 20 Years

News Daily News

Burden of CVD Still High in UK Despite Prevention Efforts Over 20 Years

Yael L. Maxwell

June 26, 2024

Time-Restricted Eating, High-Intensity Training Have Heart Benefits for Obese Women

News Daily News

Time-Restricted Eating, High-Intensity Training Have Heart Benefits for Obese Women

May 07, 2024

Top General Cardiology and CVD Prevention News of 2023

News Daily News

Top General Cardiology and CVD Prevention News of 2023

Yael L. Maxwell

January 03, 2024

Stopping Tirzepatide Leads to Rebound in Weight, Cardiometabolic Risk

News Daily News

Stopping Tirzepatide Leads to Rebound in Weight, Cardiometabolic Risk

December 12, 2023

Mortality Risk Varies Among Patients With Very High LDL Levels

News Daily News

Mortality Risk Varies Among Patients With Very High LDL Levels

Michael O'Riordan

November 17, 2023

Lorundrostat, an Aldosterone Synthase Inhibitor, Passes Phase II Hurdle

News Daily News

Lorundrostat, an Aldosterone Synthase Inhibitor, Passes Phase II Hurdle

September 12, 2023

Longer-Term ASCVD Risk Assessment Best for Younger Patients

News Daily News

Longer-Term ASCVD Risk Assessment Best for Younger Patients

Michael O'Riordan

February 16, 2023

Obesity and CVD: New Review Highlights Where Tools and Meds Fall Short

News Daily News

Obesity and CVD: New Review Highlights Where Tools and Meds Fall Short

January 31, 2023

Exercise Keeps Athletic Heart Supple, Strong, Healthy: JACC Deep Dive

News Daily News

Exercise Keeps Athletic Heart Supple, Strong, Healthy: JACC Deep Dive

Michael O'Riordan

September 09, 2022

‘Code Blue’ for the Dire CVD Health Status of Most US Adults

News Daily News

‘Code Blue’ for the Dire CVD Health Status of Most US Adults

Michael O'Riordan

July 05, 2022

ASCVD Risk in South Asians Far Exceeds Forecasts by Common Scores

News Daily News

ASCVD Risk in South Asians Far Exceeds Forecasts by Common Scores

July 12, 2021

Sleep Apnea Awareness, Treatment May Improve Some CVD Outcomes: AHA

News Daily News

Sleep Apnea Awareness, Treatment May Improve Some CVD Outcomes: AHA

June 23, 2021

TCTMD’s Top 10 Most Popular Stories for July 2018

News Daily News

TCTMD’s Top 10 Most Popular Stories for July 2018

August 01, 2018

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.